Akrivis Technologies

Akrivis Technologies

Biotechnology, 1 Broadway, Cambridge, Massachusetts, 02142, United States, 1-10 Employees

akrivis.com

  • twitter
  • LinkedIn

phone no Phone Number: 00************

Who is AKRIVIS TECHNOLOGIES

Akrivis Technologies, LLC | 218 followers on LinkedIn. Akrivis Technologies, LLC is a privately-held biopharmaceutical company founded in 2009 and headquartered in Cambridge, MA. Akrivis ...

Read More

map
  • 1 Broadway, Cambridge, Massachusetts, 02142, United States Headquarters: 1 Broadway, Cambridge, Massachusetts, 02142, United States
  • 2009 Date Founded: 2009
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from AKRIVIS TECHNOLOGIES

Akrivis Technologies Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Akrivis Technologies

Answer: Akrivis Technologies's headquarters are located at 1 Broadway, Cambridge, Massachusetts, 02142, United States

Answer: Akrivis Technologies's phone number is 00************

Answer: Akrivis Technologies's official website is https://akrivis.com

Answer: Akrivis Technologies's revenue is $1 Million to $5 Million

Answer: Akrivis Technologies's SIC: 2834

Answer: Akrivis Technologies's NAICS: 325412

Answer: Akrivis Technologies has 1-10 employees

Answer: Akrivis Technologies is in Biotechnology

Answer: Akrivis Technologies contact info: Phone number: 00************ Website: https://akrivis.com

Answer: Akrivis Technologies, LLC | 218 followers on LinkedIn. Akrivis Technologies, LLC is a privately-held biopharmaceutical company founded in 2009 and headquartered in Cambridge, MA. Akrivis is engaged in the early diagnosis and treatment of serious and life-threatening diseases. Akrivis’ main asset is its proprietary Z-TECT™ technology platform that provides ultrasensitive detection and accurate quantification of biomolecules present down to the zeptomole range (10E–21 moles).

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access